West Pharmaceutical Services EBITDA Margin 2010-2025 | WST

West Pharmaceutical Services ebitda margin for the quarter ending March 31, 2025 was 24.65%.

  • West Pharmaceutical Services average ebitda margin for 2024 was 25.62%, a 6.8% decline from 2023.
  • West Pharmaceutical Services average ebitda margin for 2023 was 27.49%, a 10.43% decline from 2022.
  • West Pharmaceutical Services average ebitda margin for 2022 was 30.69%, a 6.45% decline from 2021.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

West Pharmaceutical Services EBITDA Margin 2010-2025 | WST

  • West Pharmaceutical Services average ebitda margin for 2024 was 25.62%, a 6.8% decline from 2023.
  • West Pharmaceutical Services average ebitda margin for 2023 was 27.49%, a 10.43% decline from 2022.
  • West Pharmaceutical Services average ebitda margin for 2022 was 30.69%, a 6.45% decline from 2021.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.